The goal of our webinars is to provide direct answers to people with ALS, their families and others involved or interested in research leading to the development of effective treatments and cures for ALS.
The newly passed Right to Try law in the US will be discussed during this webinar.
This session will specifically outline what we think people should be on the lookout for in 2018, including where we stand with Masitinib, CopperATSM, NP001, NurOwn, AT-1501 and other potential treatments.
We will also spend some time providing a short overview of the current basic research focuses in ALS occurring across the globe, such as biomarkers, etc.
This session will be recorded and made available online following the webinar.